The role of COX-2 inhibitors in pain modulation

被引：30

作者：

Camu, F ^{[1
]}

Shi, L ^{[1
]}

Vanlersberghe, C ^{[1
]}

机构：

[1] Free Univ Brussels, Med Ctr, Dept Anesthesiol, B-1090 Brussels, Belgium

来源：

DRUGS | 2003年 / 63卷 / Suppl 1期

关键词：

D O I：

10.2165/00003495-200363001-00002

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

NSAIDs are the analgesics that are most commonly used world-wide. In the past few years, there have been significant advances in explaining the mechanism of action and clinical efficacy of the drugs belonging to this pharmacological family. Recent data relating to the role of cyclo-oxygenase (COX)-2 in the development of neuronal hyperexcitability and pain hypersensitivity have opened new perspectives in our understanding of the therapeutic effects of these drugs in several painful conditions. The main objective of this brief review is to deal with some physiopathological and pharmacological aspects concerning the role of NSAIDs, with special reference to COX-2 inhibitors, in the treatment of pain.

引用

页码：1 / 7

页数：7

共 49 条

[1] Nimesulide prevents lipopolysaccharide-induced elevation in plasma tumor necrosis factor-α in rats [J].

Azab, A ;

Fraifeld, V ;

Kaplanski, J .

LIFE SCIENCES, 1998, 63 (23) :PL323-PL327

[2] Direct activation of rat spinal dorsal horn neurons by prostaglandin E2 [J].

Baba, H ;

Kohno, T ;

Moore, KA ;

Woolf, CJ .

JOURNAL OF NEUROSCIENCE, 2001, 21 (05) :1750-1756

[3] Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation [J].

Beiche, F ;

Scheuerer, S ;

Brune, K ;

Geisslinger, G ;

GoppeltStruebe, M .

FEBS LETTERS, 1996, 390 (02) :165-169

[4]

Bennett A, 2000, Expert Opin Pharmacother, V1, P277, DOI 10.1517/14656566.1.2.277

[5]

Bennett A., 2001, THERAPEUTIC ROLES SE, P524

[6] NIMESULIDE DECREASES SUPEROXIDE PRODUCTION BY INHIBITING PHOSPHODIESTERASE TYPE-IV [J].

BEVILACQUA, M ;

VAGO, T ;

BALDI, G ;

RENESTO, E ;

DALLEGRI, F ;

NORBIATO, G .

EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 268 (03) :415-423

[7]

BEVILACQUA M, 1988, PAIN REPROD, V31, P265

[8] Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].

Bombardier, C ;

Laine, L ;

Reicin, A ;

Shapiro, D ;

Burgos-Vargas, R ;

Davis, B ;

Day, R ;

Ferraz, MB ;

Hawkey, CJ ;

Hochberg, MC ;

Kvien, TK ;

Schnitzer, TJ ;

Weaver, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528

[9]

CAPECCHI PL, 1993, ARZNEIMITTEL-FORSCH, V43-2, P992

[10] The mechanisms of action of NSAIDs in analgesia [J].

Cashman, JN .

DRUGS, 1996, 52 :13-23

← 1 2 3 4 5 →